These findings denote that tip-like and proliferative ECs are vulnerable to STING activation-induced apoptosis, and these can partly explain why only the ECs of implanted, but not spontaneous, breast cancer underwent apoptosis following cGAMP treatment. The gene discussed is STING1; the disease is breast cancer.